Fibrinogen Nottingham II: A novel Bβ Arg264gly substitution causing hypofibrinogenaemia

Thrombosis and Haemostasis

Volumn 96, Issue 3, 2006, Pages 378-380

  Hill, Marian B ^a   Brennan, Stephen O ^b   Dear, Amy ^c   Strong, Jane ^a   Nejim, Tara ^a   Dolan, Gerrard ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FIBRINOGEN; GLYCINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONTROLLED STUDY; DNA DETERMINATION; EXON; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOFIBRINOGENEMIA; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

ADULT; AFIBRINOGENEMIA; ARGININE; BINDING SITES; CALCIUM; CRYSTALLOGRAPHY, X-RAY; FEMALE; FIBRINOGEN; HUMANS; MODELS, MOLECULAR; MUTATION; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33748593365     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-03-0333     Document Type: Article

References (13)

1. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005;70:247-99.
2. Standeven KF, Ariens RA, Grant PJ. The molecular physiology and pathology of fibrin structure/function. Blood Rev 2005; 19: 275-88.
3. Maghzal GJ, Brennan SO, Homer VM, et al. The molecular mechanisms of congenital hypofibrinogenaemia. Cell Mol Life Sci 2004; 61: 1427-38.
4. Hill M, Deam S, Gordon B, et al. Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinica phenotype. Haemophilia 2005; 11: 133-41.
5. Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997; 78: 1055-8.
6. Brennan SO, Fellowes AP, Faed JM, et al Hypofibrinogenemia in an individual with 2 coding (β82 A>G and Bβ235 PL) and 2 non-coding mutations. Blood 2000,95:1709-13
7. Maghzal GJ, Brennan SO, Fellowes AP, et al. Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bβ255 Arg>His (Fibrinogen Merivale). Biochim Biophys Acta 2003; 1645: 146-51.
8. Brennan SO, Wyatt JM, May S, et al. Hypofibrinogenemia due to novel 316 Asp>Tyr substitution in the fibrinogen Bβ chain. Thromb Haemost 2001; 85: 450-3.
9. Duga S, Asselta R, Santagostino E, et al. Missense mutations in the human β fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood 2000; 95: 1336-41.
10. Vu D, Bolton-Maggs PH, Parr JR, et al. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood 2003; 102: 4413-5.
11. Spena. S, Asselta F, Duga S, et al. Congenital afibrinogenemia: intracellular retention of fibrinogen due to a novel W437G mutation in the fibrinogen Bβ-chain gene. Biochim Biophys Acta 2003; 1639: 87-94.
12. Kostelansky MS, Betts L, Gorkun OV et al. 2.8 A crystal structure of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the 'b' site disrupts its nearby calcium-binding site. Biochemistry 2002; 41: 12124-32.
13. Kostelansky MS, Louncs KC, Ping LF, et al. Calcium-binding site β2, adjacent to the 'b' polymerization site, modulates lateral aggregation of protofibrils during fibrinogen polymerization. Biochemistry 2004; 43:2475-83.